Interactions between endothelin-1-induced contractions and bronchodilators in human isolated bronchi

Clinical Science

Volumn 93, Issue 6, 1997, Pages 527-533

  Clayton, Robert A ^a   Nally, Jane E ^b   Thomson, Neil C ^c   McGrath, John C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Bronchi; Endothelin 1; Isosorbide dinitrate; Salbutamol; Sodium nitroprusside

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRONCHODILATING AGENT; ENDOTHELIN 1; ISOSORBIDE DINITRATE; METHACHOLINE; NITROPRUSSIDE SODIUM; SALBUTAMOL; SPASMOGEN; BRONCHOCONSTRICTING AGENT; METHACHOLINE CHLORIDE;

ARTICLE; BRONCHOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT;

ALBUTEROL; ATRIAL NATRIURETIC FACTOR; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; HUMANS; ISOSORBIDE DINITRATE; METHACHOLINE CHLORIDE; NITROPRUSSIDE;

EID: 0030666869     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930527     Document Type: Article

References (36)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 1988; 332: 411-15.
2. Black PN, Ghatei D, Takahashi D, et al. Formation of endothelin by cultured airway epithelial cells. FEBS Lett 1989; 225: 129.
3. Mattoli S, Mezzetti M, Riva L, Allegra L, Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol 1990; 3: 145-51.
4. Rubanyi GM, Polokoff MA. Endothelins: molecular-biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
5. Uchida Y, Ninomiya H, Saotome M, et al. Endothelin, a novel vasoconstrictor, as potent bronchoconstrictor. Eur J Pharmacol 1988; 154: 227-8.
6. Henry PJ, Rigby PJ, Self GJ, Preuss JM, Goldie RG. Relationship between endothelin-1 binding sice densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol 1990; 100: 786-92.
7. Springall DR, Howarth PH, Counihan H, Djukanovic R, Holgate ST, Polak JM. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991; 337: 697-701.
8. Advenier C, Sarria B, Naline E, Puybasset L, Lagente V. Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol 1990; 100: 168-72.
9. Nomura A, Uchida Y, Kameyama M, Saotome M, Oki K, Hasegawa S. Endothelin and bronchial asthma. Lancet 1989; ii: 747-8.
10. Payne AN, Whittle BJR. Potent cyclo-oxygenase-mediated bronchoconstrictor effect of endothelin in the guinea-pig in vivo. Eur J Pharmacol 1988; 158: 303.
11. McKay KO, Black JL, Armour CL. Phosphoramidon potentiates the contractile response to endothelin-3 but not endothelin-1 in isolated airway tissue. Br J Pharmacol 1992; 105: 929-32.
12. Nally JE, McCall R, Young LC, Wakelam MJO, Thomson NC, McGrath JC. Mechanical and biochemical responses to endothelin-1 and endothelin-3 in bovine bronchial smooth muscle. Br J Pharmacol 1994; 111: 1163-9.
13. Nally JE, McCall R, Young LC, Wakelam MJO, Thomson NC, McGrath JC. Mechanical and biochemical responses to endothelin-1 and endothelin-3 in human bronchi. Eur J Pharmacol 1994; 288: 53-60.
14. Brink C, Grimaud C, Guillot, C, Orehek J. The interaction between indomethacin and contractile agents on human isolated airway muscle. Br J Pharmacol 1980; 69: 383-8.
15. Angus RM, Nally JE, McCall R, Young LC, McGrath JC, Thomson NC. Modulation of the effect of atrial natriuretic peptide in human and bovine bronchi by phosphoramidon. Clin Sci 1994; 86: 291-5.
16. MacLean MR, Templeton, AGB, McGrath JC. The influence of endothelin-1 on human foeto-placental blood vessels: a comparison with 5-hydroxydopamine. Br J Pharmacol 1992; 106: 937-41.
17. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad FK, Rapoport R. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulars guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 1984; 81: 7661-4.
18. Ohlstein EH, Berkowitz BA. Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic peptide. Hypertension 1985; 7: 306-10.
19. Ishii K, Murad F. ANP relaxes bovine tracheal smooth muscle and increases cGMP. Am J Physiol 1989; 256: C495-500.
20. Angus RM, MacCallum MJA, Hulks G, Thomson NC. The bronchodilator, cardiovascular and cyclic guanylyl monophosphate (cGMP) response to high dose infused atrial natriuretic peptide in asthma. Am Rev Respir Dis 1993; 147: 1122-5.
21. Hulks G, Jardine A, Connell, JMC, Thomson NC. Bronchodilator effect of atrial natriuretic peptide in asthma. Br J Med 1989; 299: 1081-2.
22. Miura M, Belvisi MG, Stretton CD, Yacoub MH, Barnes PJ. Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis 1992; 146: 132-6.
23. Rinard GA, Jensen A, Plunkett MA. Hydrocortisone and isoproterenol effects on trachealis cAMP and relaxation. J Appl Physiol 1983; 55: 1609-13.
24. Ignarro LJ, Kadowitz PJ. The pharmacological role of cGMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 1985; 25: 171-91.
25. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of s-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-49.
26. Tattersfield AE. Effect of beta-agonist and anticholinergic drugs on bronchial reactivity. Am Rev Respir Dis 1987; 136: S64-8.
27. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Protective effect of drugs on histamine-induced asthma. Thorax 1977; 32: 429-37.
28. Salome CM, Schoeffel RE, Woolcock AJ. Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects. Thorax 1981; 36: 580-4.
29. Britton J, Hanley SP, Garrett HV, Hadfield JW, Tatterfield AE. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 1988; 43: 300-5.
30. Peters SP, Schulman ES, Schleimer RP, Macglashan DW, Newball HH, Lichenstein LM. Dispersed human lung mast cells. Pharmacological aspects and comparison with human lung tissue fragments. Am Rev Respir Dis 1982; 126: 1034-9.
31. Butchers PR, Skidmore IF, Vardey CJ, Wheeldon A. Characterization of the receptor mediating the ami-anaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol 1960; 71: 663-7.
32. Persson CGA, Erjefalt I, Grega GJ, Svensjo E. The role of β-receptor agonists in the inhibition of pulmonary edema. Ann N Y Acad Sci 1982; 384: 544-57.
33. Grandordy BM, Cuss FM, Sampson AS, Palmer JB, Barnes PJ. Phosphatidylinositol response to cholinergic agonists in airway smooth muscle; relationship to contraction and muscarinic receptor occupancy. J Pharm Exp 1986; 238: 273-9.
34. Mattoli S, Soloperto M, Mezzetti M, Fasoli A. Mechanisms of calcium mobilization and phosphoinositide hydrolysis in human bronchial smooth muscle cells by endothelin-1. Am J Respir Cell Mol Biol 1991; 5: 424-30.
35. Burgess GM, McKinney JS, Fabiato A, Lesley BA, Putney JW. Calcium pools in saponin-permeabilized guinea-pig hepatocytes. J Biol Chem 1983; 258: 15336-45.
36. Nishizuka Y. Phospholipid degeneration and signal transduction for protein phosphorylation. Trends Biochem Sci 1983; 8: 13-16.